Downregulation of otulin induces inflammasome activation in neutrophilic asthma

• Published in: Journal of allergy and clinical immunology Vol. 154; no. 3; pp. 557 - 570
• Main Authors: Quoc, Quang Luu, Kim, YeJi, Park, Gunwoo, Cao, Thi Bich Tra, Choi, Youngwoo, Park, Yong Hwan, Park, Hae-Sim
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2024
• Subjects: Macrophage; neutrophils; otulin; severe asthma; therapy; αTNF-α; AHR; BMDM; MPO; SA; ILC3; RIPK; severe asthma; KD; Mφ; NLRP3; EA; neutrophils; AEC; otulin; KO; therapy; BALF; CM; siRNA; AM; LUBAC; FVC; NA; JAK; ICS; NCM; FEV1; HC; OVA; NET; MMP-9; dsDNA; Macrophage
• ISSN: 0091-6749; 1097-6825; 1097-6825
• DOI: 10.1016/j.jaci.2024.03.021

[Display omitted] Neutrophilic asthma (NA) is a severe asthma phenotype associated with steroid resistance and IL-1β overproduction; however, the exact mechanism remains unclear. Moreover, the dysfunction of TNF-α signaling pathway, a regulator of IL-1β production, was associated with the deficiency of ovarian tumor protease deubiquitinase with linear linkage specificity (otulin) in autoimmune patients. We hypothesized that otulin downregulation in macrophages (Mφ) could trigger Mφ activation via the nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) inflammasome signaling pathway. We assessed the expressions of otulin in blood monocyte subsets from NA patients and in alveolar Mφ from NA mice. Additionally, we evaluated the functional consequences of otulin deficiency in bone marrow–derived Mφ. The effects of inhibiting receptor-interacting protein kinase (RIPK)-1 and RIPK-3 on neutrophils and group 3 innate lymphoid cells (ILC3s) were assessed in vitro and in vivo. When comparing nonclassical monocytes, a significant downregulation of otulin in the intracellular components was observed in NA patients compared to healthy controls (P = .005). Moreover, isolated alveolar Mφ from the NA mice exhibited lower otulin expression compared to those from control mice. After otulin knockdown in bone marrow–derived Mφ, we observed spontaneous IL-1β production depending on NLRP3 inflammasome. Moreover, the infiltrated neutrophils and ILC3s were significantly decreased by combined treatment of RIPK-1 and RIPK-3 inhibitors through blocking IL-1β release in NA. IL-1β overproduction caused by a deficiency of otulin, an upstream triggering factor, could be a promising diagnostic and therapeutic target for NA.